Research Article

Role of plants, environmental toxins and physical neurotoxicological factors in Amyotrophic lateral sclerosis, Alzheimer Disease and other Neurodegenerative Diseases

Mauro Luisetto*, Naseer Almukhtar, Ahmed Yesvi Rafa, Behzad Nili Ahmadabadi, Ghulam Rasool Mashori, Farhan Ahmad Khan, Ram Kumar Sahu, Gamal Abdul Hamid and Khaled Edbey

Published: 03/04/2019 | Volume 3 - Issue 1 | Pages: 001-086

Abstract

Aim of this work is to verify the effect of some neurotoxins, physical factors and geography in presentation of some Relevant Neurological disorder like some form of ASL, PD, AD.

The geographic diffusion of the ASL/PD in west pacific (GUAM foci), and mutation of SOD 1 and other mutations are interesting facts to verify the recent literature about the neurotoxic process.

Related to the references presented a global conclusion about the pathogenetic progression of some neurological disease will be produced as instrument for new hypothesis and for the introduction of new innovative therapeutic strategies.

Read Full Article HTMLDOI: 10.29328/journal.jnnd.1001019Cite this Article

References

  1. Escobar-Khondiker M, Höllerhage M, Muriel MP, Champy P, Bach A, et al. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci. 2007; 27: 7827-7837. Ref.: https://goo.gl/3cFDm8
  2. N Bonneau, J Le Ven, I Schmitz-Afonso, V Guérineau, I Bajin ba Ndob, et al. Annonaceous acetogenins as environmental neurotoxins: Human exposure from edible Annona fruits. Planta Med. 2012; 78 - PH25. Ref.: https://goo.gl/fdZdir
  3. Lannuzel A, Michel PP, Caparros-Lefebvre D, Abaul J, Hocquemiller R, et al. Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe. Mov Disord. 2002;17: 84-90. Ref.: https://goo.gl/NhQaGs
  4. Höllerhage M, Rösler TW, Berjas M, Luo R, Tran K, et al. Neurotoxicity of Dietary Supplements from Annonaceae Species. Int J Toxicol. 2015; 34: 543-550. Ref.: https://goo.gl/3Dn27B
  5. Zafra-Polo MC, González MC, Estornell E, Sahpaz S, Cortes D. Acetogenins from Annonaceae, inhibitors of mitochondrial complex I. Phytochemistry. 1996; 42: 253-271. Ref.: https://goo.gl/Sdmqi2
  6. P. N'Gouemo, B. Koudogbo, H. Pambou Tchivounda, C. Akono‐Nguema, Minko M. Etoua
  7. Effects of ethanol extract of Annona muricata on pentylenetetrazol‐induced convulsive seizures in mice. Short Communication. 1998. Ref.: https://goo.gl/Dgr8fR
  8. Moghadamtousi SZ, Rouhollahi E, Hajrezaie M, Karimian H, Abdulla MA, et al. Annona muricata leaves accelerate wound healing in rats via involvement of Hsp70 and antioxidant defence. Int J Surg. 2015; 18: 110-117. Ref.: https://goo.gl/S8fkmi
  9. Chen Y, Chen JW, Zhai JH, Wang Y, Wang SL, et al. Antitumor activity and toxicity relationship of annonaceous acetogenins. Food Chem Toxicol. 2013; 58: 394-400. Ref.: https://goo.gl/7jsbTN
  10. Ribeiro Ldo P, Zanardi OZ, Vendramim JD, Yamamoto PT. Comparative toxicity of an acetogenin-based extract and commercial pesticides against citrus red mite. Exp Appl Acarol. 2014; 64: 87-98. Ref.: https://goo.gl/vnpnc7
  11. Levine RA, Richards KM, Tran K, Luo R, Thomas AL, et al. Determination of Neurotoxic Acetogenins in Pawpaw (Asimina triloba) Fruit by LC-HRMS. J Agric Food Chem. 2015; 63: 1053-1056. Ref.: https://goo.gl/WBmX6q
  12. Jiang Z, Wang W, Perry G, Zhu X, Wang X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl Neurodegener. 2015; 4: 14. Ref.: https://goo.gl/vxJowD
  13. Ravindranath V. Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by L-beta-oxalyl aminoalanine. Neurochem Int. 2002; 40: 505-509. Ref.: https://goo.gl/AueXgQ
  14. Potts LF, Luzzio FA, Smith SC, Hetman M, Champy P, et al. Annonacin in Asimina triloba fruit: Implication for neurotoxicity. Neurotoxicology. 2012; 33: 53-58. Ref.: https://goo.gl/qi3SpF
  15. Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, et al. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem. 2005; 280: 42026-42035. Ref.: https://goo.gl/yYvYvH
  16.  Shen WB, McDowell KA, Siebert AA, Clark SM, Dugger NV, et al. Environmental neurotoxin-induced progressive model of parkinsonism in rats. Ann Neurol. 2010; 68: 70-80. Ref.: https://goo.gl/3M1CtV
  17. Scott LL, Downing TG. B-N-Methylamino-l-alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats. Toxins (Basel). 2018; 10: 16. Ref.: https://goo.gl/69V7GM
  18. Uversky VN. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004; 318: 225-241. Ref.: https://goo.gl/3Erqvj
  19. de Pedro N, Cautain B, Melguizo A, Vicente F, Genilloud O, Peláez F, et al. Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway. J Bioenerg Biomembr. 2013; 45: 153-164. Ref.: https://goo.gl/YqcVof
  20. Degli Esposti M, Ghelli A, Ratta M, Cortes D, Estornell E. Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). Biochem J. 1994; 301: 161-167. Ref.: https://goo.gl/gqXFpE
  21. Segura Aguilar J, Kostrzewa RM. Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox Res. 2004; 6: 615-630. Ref.: https://goo.gl/h1K7Sc
  22. Caparros-Lefebvre D, Steele J, Kotake Y, Ohta S. Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins. Mov Disord. 2006; 21: 1769-1771. Ref.: https://goo.gl/twX6pZ
  23. Khandare AL, Kumar RH, Meshram II, Arlappa N, Laxmaiah A, et al. Current scenario of consumption of Lathyrus sativus and lathyrism in three districts of Chhattisgarh State, India. Toxicon. 2018; 150: 228-234. Ref.: https://goo.gl/Kf6kGC
  24. Salama M, Arias-Carrión O. Natural toxins implicated in the development of Parkinson’s disease. Ther Adv Neurol Disord. 2011; 4: 361-373. Ref.: https://goo.gl/fo1KA7
  25. Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016; 31: 7-19. Ref.: https://goo.gl/UpPN7K
  26. Pan-Montojo F, Reichmann H. Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology. Transl Neurodegener. 2014; 3: 10. Ref.: https://goo.gl/EJ9URY
  27. Rafael H, David JO, Vilca AS. Etiology and treatment of amyotrophic lateral sclerosis. Am J Neurodegener Dis. 2017; 6: 1-8. Ref.: https://goo.gl/rtZ4Ra
  28. Das K, Nag C, Ghosh M. Familial, Environmental, and Occupational Risk Factors in Development of Amyotrophic Lateral Sclerosis. N Am J Med Sci. 2012; 4: 350-355. Ref.: https://goo.gl/s1hzKe
  29. Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012; 117: 112-119. Ref.: https://goo.gl/WU5nH4
  30. Zhou H, Chen G, Chen C, Yu Y, Xu Z. Association between extremely low-frequency electromagnetic fields occupations and amyotrophic lateral sclerosis: a meta-analysis. PLoS One. 2012; 7: e48354. Ref.: https://goo.gl/HfDCt4
  31. Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2003; 61: 387-389. Ref.: https://goo.gl/Y6kXf2
  32. Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003; 100: 13380-13383. Ref.: https://goo.gl/Xm4YVK
  33. Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015; 7: 181-193. Ref.: https://goo.gl/Lgk4yL
  34. Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010; 67: 739-748. Ref.: https://goo.gl/v2VJqB
  35. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004; 10: S10-S17. Ref.: https://goo.gl/JoNjK7
  36. Huss A, Spoerri A, Egger M, Kromhout H, Vermeulen R, et al. Occupational exposure to magnetic fields and electric shocks and risk of ALS: the Swiss National Cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16: 80-85. Ref.: https://goo.gl/W5AeYm
  37. Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis?  F1000Res. 2017; 6: 371. Ref.: https://goo.gl/KJTgiH
  38. Abhinav K, Al-Chalabi A, Hortobagyi T, Leigh PN. Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2007; 78: 450-453. Ref.: https://goo.gl/8TSPgf
  39. Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014; 4: e005528. Ref.: https://goo.gl/mGcWPh
  40. Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009–2011. Am J Epidemiol. 2015; 182: 512-519. Ref.: https://goo.gl/mD75DD
  41. Rooney J, Heverin M, Vajda A, Crampsie A, Tobin K, et al. An Exploratory Spatial Analysis of ALS Incidence in Ireland over 17.5 Years (1995 – July 2013). PLoS One. 2014; 9: e96556. Ref.: https://goo.gl/jCeEyt
  42. Logroscino G, Piccininni M. Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference. Neuroepidemiology. 2019; 52: 93-103. Ref.: https://goo.gl/2hDwXo
  43. Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009; 32: 81-88. Ref.: https://goo.gl/ZrVzPN
  44. Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, et al. Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia. PLoS One. 2014; 9: e93932. Ref.: https://goo.gl/5hjGV4
  45. Kokubo Y, Kuzuhara S, Narita Y. Geographical distribution of amyotrophic lateral sclerosis with neurofibrillary tangles in the Kii Peninsula of Japan. J Neurol. 2000; 247: 850-852. Ref.: https://goo.gl/oqGkV8
  46. Virginia Bozzoni, Orietta Pansarasa, Luca Diamanti, Guido Nosari, Cristina Cereda, et al. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016; 31: 7-19. Ref.: https://goo.gl/WpMiMG
  47. Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, et al. Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan. PLoS One. 2014; 9: e101186. Ref.: https://goo.gl/USCX5B
  48. Kuzuhara S. [ALS-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease). Historical review, epidemiology and concept]. Rinsho Shinkeigaku. 2007; 47: 962-965. Ref.: https://goo.gl/dGrJ61
  49. Zarei S, Carr K, Reiley L, Diaz K, Guerra O, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015; 6: 171. Ref.: https://goo.gl/WAWsUw
  50. Ludolph AC, Hugon J, Dwivedi MP, Schaumburg HH, Spencer PS. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases. Brain. 1987; 110: 149-465. Ref.: https://goo.gl/Z7Q7KU
  51. Khandare AL, Babu JJ, Ankulu M, Aparna N, Shirfule A, et al. Grass pea consumption & present scenario of neurolathyrism in Maharashtra State of India. Indian J Med Res. 2014; 140: 96-101. Ref.: https://goo.gl/bW4wgx
  52. Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007; 22: 781-790. Ref.: https://goo.gl/548yma
  53. Schwartz GG, Rundquist BC, Simon IJ, Swartz SE. Geographic distributions of motor neuron disease mortality and well water use in U.S. counties. Amyotroph Lateral Scler Frontotemporal Degener. 2017; 18: 279-283. Ref.: https://goo.gl/uDefbU
  54. Li W, Lee MH, Henderson L, Tyagi R, Bachani M, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015; 7: 307ra153. Ref.: https://goo.gl/FbY7so
  55. Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009; 10: 205-209. Ref.: https://goo.gl/BdqgVD
  56. Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005; 128: 472-476. Ref.: https://goo.gl/yz7Ubm
  57. Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol. 2005; 20: 237-242. Ref.: https://goo.gl/r2Zfg3
  58. Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014; 4: e005528. Ref.: https://goo.gl/RKPkSP
  59. Manzano GM, Giuliano LM, Nóbrega JA. A brief historical note on the classification of nerve fibers Arq Neuropsiquiatr. 2008; 66: 117-119. Ref.: https://goo.gl/8ZcD7C
  60. Tapia R. Cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: a perspective. Front Cell Neurosci. 2014; 8: 241. Ref.: https://goo.gl/bLTZqR
  61. Bélanger M, Allaman I, Magistretti PJ. Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation. Cell Metab. 2011; 14: 724-738. Ref.: https://goo.gl/6WLzWp
  62. Falkowska A, Gutowska I, Goschorska M, Nowacki P, Chlubek D, et al. Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism. Int J Mol Sci. 2015; 16: 25959-25981. Ref.: https://goo.gl/smjsmd
  63. Bertamini M, Marzani B, Guarneri R, Guarneri P, Bigini P, et al. Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur J Neurosci. 2002; 16: 2291-2296. Ref.: https://goo.gl/KVDq6F
  64. Tefera TW, Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front Neurosci. 2016; 10: 611. Ref.: https://goo.gl/EhcDe5
  65. Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol. 2005; 20: 237-242. Ref.: https://goo.gl/kMmb95
  66. Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012; 117: 112-119. Ref.: https://goo.gl/bA3Xie
  67. Alessandro Cristani, Elisa Romagnoli. Storia del rapporto tra sclerosi laterale amiotrofica e sport: alla ricerca dell’etiopatogenesi sconosciuta. Recenti Progressi Medicina. 2006. Ref.: https://goo.gl/33y53X
  68. Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, et al. Prevalence of potential sports‐associated risk factors in Swiss amyotrophic lateral sclerosis patients. Brain Behav. 2017; 7: e00630. Ref.: https://goo.gl/ikToDA
  69. Vargas MI, Gariani J, Sztajzel R, Barnaure-Nachbar I, Delattre BM, et al. Spinal Cord Ischemia: Practical Imaging Tips, Pearls, and Pitfalls. AJNR Am J Neuroradiol. 2015; 36: 825-830. Ref.: https://goo.gl/n8L7zd
  70. Mauro Luisetto , Behzad N-A, Nilesh MM, Ghulam RM, Ram KS, et al. Amyotrophic Lateral Sclerosis and Endogenous-Esogenous Toxicological Movens: New Model to Verify Other Pharmacological Strategies. Arch Pathol Clin Res. 2018; 2: 28-48. Ref.: https://goo.gl/QpkZd6
  71. Kim S, Kim H, Kralik JD, Jeong J. Vulnerability-Based Critical Neurons, Synapses, and Pathways in the Caenorhabditis elegans Connectome. PLoS Comput Biol. 2016; 12: e1005084. Ref.: https://goo.gl/HedD1H
  72. Caller TA, Chipman JW, Field NC, Stommel EW. Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009. Muscle Nerve. 2013; 48: 235-241. Ref.: https://goo.gl/cSWyYs
  73. Lee BC, Johng HM, Lim JK, Jeong JH, Baik KY, et al. Effects of extremely low frequency magnetic field on the antioxidant defense system in mouse brain: a chemiluminescence study. J Photochem Photobiol B. 2004; 73: 43-48. Ref.: https://goo.gl/bsRTqj
  74. Piazza O, Sirén AL, Ehrenreich H. Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin. 2004; 20: 505-508. Ref.: https://goo.gl/X5g9Zd
  75. Scotter EL, Chen HJ, Shaw CE. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015; 12: 352-363. Ref.: https://goo.gl/NkJD6Q
  76. Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, et al. Protein misfolding in neurodegenerative diseases: implications and strategie. Transl Neurodegener. 2017; 6: 6. Ref.: https://goo.gl/4RdYnD